MyoD undergoes a distinct G2/M-specific regulation in muscle cells

Experimental Cell Research

Volumn 312, Issue 20, 2006, Pages 3999-4010

  Batonnet Pichon, Sabrina ^a,b,c   Tintignac, Lionel J ^a,b,c   Castro, Anna ^b   Sirri, Valentina ^c   Leibovitch, Marie Pierre ^a   Lorca, Thierry ^b   Leibovitch, Serge A ^a  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b Centre National de la Recherche Scientifique   (France)

^c INSTITUT JACQUES MONOD   (France)

Author keywords

G2 M transition; Mitotic stabilization; MyoD; Phosphorylation

Indexed keywords

CYCLIN B; DNA; MYOD PROTEIN; SERINE;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CHROMATIN; CHROMOSOME; CONTROLLED STUDY; DNA BINDING; EMBRYO; FEMALE; HUMAN; HUMAN CELL; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 33751518802     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.09.001     Document Type: Article

References (35)

1. Bergstrom D.A., Penn B.H., Strand A., Perry R.L., Rudnicki M.A., and Tapscott S.J. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9 (2002) 587-600
2. Weintraub H. The MyoD family and myogenesis: redundancy, networks and thresholds. Cell 75 (1993) 1241-1244
3. Kitzmann M., Carnac G., Vandromme M., Primig M., Lamb N., and Fernandez A. The muscle regulatory factors MyoD and Myf-5 undergo distinct cell cycle-specific expression in muscle cells. J. Cell Biol. 142 (1998) 1447-1459
4. Song A., Wang Q., Goebl M.G., and Harrington M.A. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol. Cell Biol. 18 (1998) 4994-4999
5. Tintignac L.A., Leibovitch M.P., Kitzmann M., Fernandez A., Ducommun B., Meijer L., and Leibovitch S.A. CyclinE-Cdk2 phosphorylation promotes late G1-phase degradation of MyoD1 in muscle cells. Exp. Cell Res. 259 (2000) 300-307
6. Baus Charrier-Savourin F., Château M.-T., Gire V., Sedivy J., Piette J., and Dulic V. p21-mediated Nuclear retention of cyclinB1-Cdk1 in response to genotoxic stress. Mol. Biol. Cell 15 (2004) 3965-3976
7. Tintignac L.A., Sirri V., Leibovitch M.P., Lécluse Y., Castedo M., Metivier D., Kroemer G., and Leibovitch Serge A. Mutant MyoD lacking Cdc2 phosphorylation sites delays M-Phase entry. Mol. Cell Biol. 24 (2004) 1809-1821
8. Wyzykowski J.C., Winata T.I., Mitin N., Taparowsky E.J., and Konieczny S.F. Identification of novel MyoD gene targets in proliferating myogenic stem cells. Mol. Cell Biol. 17 (2002) 6199-6208
9. Lindon C., Montarras D., and Pinset C. Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts. J. Cell Biol. 140 (1998) 111-118
10. Lindon C., Albagli O., Domeyne P., Montarras D., and Pinset C. Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain. Mol. Cell Biol. 23 (2000) 8923-8932
11. Doucet C., Gutierrez G.J., Lindon C., Lorca T., Lledo G., Pinset C., and Coux O. Multiple phosphorylation events control mitotic degradation of the muscle transcription factor Myf5. BMC Biochem. 6 27 (2005) 1-15
12. Lorca T., Castro A., Martinez A.M., Vigneron S., Morin N., Sigrist S., Lehner C., Doree M., and Labbe J.-C. Fizzy is required for activation of the APC/cyclosome in Xenopus egg extracts. EMBO J. 17 (1998) 3565-3575
13. Lenormand J.-L., Benayoun B., Guillier M., Vandromme M., Leibovitch M.-P., and Leibovitch S.A. Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins. Mol. Cell Biol. 2 (1997) 584-593
14. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
15. Kitzmann M., and Fernandez A. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol. Life Sci. 58 (2001) 571-579
16. Fang G., Yu H., and Kirschner MW. Direct binding of cdc20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol. Cell 2 (1998) 163-171
17. Visintin R., Prinz S., and Amon A. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 278 (1997) 460-463
18. Castro A., Arlot-Bonnemains Y., Vigneron S., Labbe J.-C., Prigent C., and Lorca T. APC/Fizzy-related targets aurora-A kinase for proteolysis. EMBO Rep. 5 (2002) 457-462
19. Den Elzen N., and Pines J. Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J. Cell Biol. 153 (2001) 121-136
20. Geley S., Kramer E., Gieffers C., Gannon J., Peters J.-M., and Hunt T. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol. 153 (2001) 137-148
21. Zhang J.-M., Wei Q., Zhao X., and Paterson B.M. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J. 18 (1999) 926-933
22. Batonnet S., Leibovitch M.-P., Tintignac L., and Leibovitch S.A. Critical role for the lysine K133 in the nuclear ubiquitin-mediated degradation of MyoD. J. Biol. Chem. 279 (2004) 5413-5420
23. Gottesfeld J.M., Wolf V.J., Dang T., Forbes D.J., and Hartl P. Mitotic repression of RNA polymerase III transcription in vitro mediated by phosphorylation of a TFIIIB component. Science 263 (1994) 81-84
24. Gottesfeld J.M., and Forbes D.J. Mitotic repression of the transcriptional machinery. Trends Trends Biochem. Sci. 6 (1997) 197-202
25. Martinez-Balbas M., Dey A., rabindran S.K., Ozato K., and Wu C. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 83 (1995) 29-38
26. Roberts S.B., Segil N., and Heintz N. Differential phosphorylation of transcription factor Oct1 during the cell cycle. Science 253 (1991) 1022-1026
27. Abu-Hatoum O.A., Gross-Mesilaty S., Breitschopf K., Hoffman A., Gonen H., Ciechanover A., and Bengal E. Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding. Mol. Cell Biol. 18 (1998) 5670-5677
28. Kitzmann M., Vandromme M., Schaeffer V., Carnac G., Labbe J.-C., Lamb N., and Fernandez A. cdk1- and cdk2-Mediated Phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol. Cell Biol. 19 (1999) 3167-3176
29. Mailand N., Podtelejnikov A.V., Groth A., Mann M., Bartek J., and Lukas J. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J. 21 (2002) 5911-5920
30. Bassermann F., von Klitzing C., Munch S., Bai R.Y., Kawaguchi H., Morris S.W., Peschel C., and Duyster J. NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry. Cell 122 (2005) 45-57
31. Muchardt C., Reyes J.C., Bourachot B., Leguoy E., and Yaniv M. The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J. 15 (1996) 3394-3402
32. Reyes J.C., Muchardt C., and Yaniv M. Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J. Cell Biol. 137 (1997) 263-274
33. Dutertre S., Sekhri R., Tintignac L.A., Onclercq-Delic R., Chatton B., Jaulin C., and Amor-Gueret M. Dephosphorylation and subcellular compartment change of the mitotic Bloom's syndrome DNA helicase in response to ionizing radiation. J. Biol. Chem. 277 (2002) 6280-6286
34. Gerber A.N., Klesert T.R., Bergstrom D.A., and Tapscott S.J. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 4 (1997) 436-450
35. Berkes C.A., Bergstrom D.A., Penn B.H., Seaver K.J., Knoepfler P.S., and Tapscott S.J. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol. Cell 14 (2004) 465-477